Iminosugar Amino Acid idoBR1 Reduces Inflammatory Responses in Microglia

  • OA Olajide
  • , VU Iwuanyanwu
  • , OW Banjo
  • , A Kato
  • , YB Penkova
  • , GWJ Fleet
  • , RJ Nash*
  • *Awdur cyfatebol y gwaith hwn

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

5 Dyfyniadau (Scopus)
56 Wedi eu Llwytho i Lawr (Pure)

Crynodeb

Background
Inflammation is reported to be a key factor in neurodegeneration. The microglia are immune cells present in the central nervous system; their activation results in the release of inflammatory cytokines and is thought to be related to aging and neurodegenerative disorders, such as Alzheimer’s disease.

Methods
A mouse BV-2 microglia cell line was activated using LPS and the anti-inflammatory cucumber-derived iminosugar amino acid idoBR1, (2R,3R,4R,5S)-3,4,5-trihydroxypiperidine-2-carboxylic acid, was used alongside dexamethasone as the control to determine whether it could reduce the inflammatory responses.

Results
A dose-dependent reduction in the LPS-induced production of the proinflammatory factors TNFα, IL-6, and nitric oxide and the transcription factor NF-κB was found.

Conclusions
Further investigations of the anti-inflammatory effects of idoBR1 in other models of neurodegenerative diseases are warranted.
Iaith wreiddiolSaesneg
Rhif yr erthygl3342
Nifer y tudalennau11
CyfnodolynMolecules
Cyfrol27
Rhif cyhoeddi10
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 23 Mai 2022
Cyhoeddwyd yn allanolIe

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Iminosugar Amino Acid idoBR1 Reduces Inflammatory Responses in Microglia'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn